1887

n Cardiovascular Journal of South Africa - Perindopril (Coversyl(R)) prevents cardiovascular death and MI in coronary disease patients regardless of their cardiovascular risk : drug trends in cardiology

Volume 14, Issue 5
  • ISSN : 1680-0745
USD

 

Abstract

Extracted from text ... 277 Perindopril* (Coversyl(r)) prevents cardiovascular death and MI in coronary disease patients regardless of their cardiovascular risk The long-acting ACE inhibitor perindopril (Coversyl(r)) significantly reduces the risk of cardiovascular death and heart attacks in patients with stable coronary disease which includes patients with angina and or a previous heart attack, according to results from the landmark EUROPA study1 (EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease), announced today at the European Society of Cardiology (ESC) annual meeting. EUROPA is the largest study ever conducted in patients with stable coronary disease. The study involved 12 218 ..

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/cardio/14/5/EJC23866
2003-09-01
2017-03-28

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error